Summary
Johnson & Johnson (JNJ) filed an 8-K on October 15, 2024, to report its third-quarter 2024 financial results, which concluded on September 29, 2024. The filing primarily directs investors to the attached press release (Exhibit 99.1) for detailed sales and earnings information. While the 8-K itself does not contain the specific figures, it serves as the official notification and repository for the company's performance disclosure for the quarter.
Key Highlights
- 1Johnson & Johnson filed an 8-K on October 15, 2024, related to its Q3 2024 financial results.
- 2The report covers the third quarter ended September 29, 2024.
- 3Key financial details regarding sales and earnings are provided in an attached press release (Exhibit 99.1).
- 4Additional supplementary sales data and condensed consolidated statements of earnings are also included as exhibits (Exhibit 99.2).
- 5This filing formally announces the company's quarterly performance to the market.
- 6Investors should refer to the referenced exhibits for the specific financial performance data.
Frequently Asked Questions
The main purpose of this 8-K filing is to officially announce and provide access to Johnson & Johnson's financial results for the third quarter of 2024, which ended on September 29, 2024. It directs investors to the accompanying press release and supplementary financial data for the specific performance details.
The actual sales and earnings figures for the third quarter of 2024 are located within Exhibit 99.1 (the press release) and Exhibit 99.2 (unaudited comparative supplementary sales data and condensed consolidated statements of earnings) attached to this 8-K filing.
The exhibits, particularly Exhibit 99.2, provide data for the fiscal third quarter and the nine months ended September 29, 2024.